METAGENOMI
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
METAGENOMI
Industry:
Artificial Intelligence Biotechnology Machine Learning
Founded:
2018-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.metagenomi.co
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
276.97 M USD
Technology used in webpage:
SSL By Default LetsEncrypt Euro Amazon Amazon Virginia Region Amazon Route 53 Amazon Oregon Region FreshService
Similar Organizations
Doxel
Doxel delivers an AI-powered project controls platform that predicts costly delays and cost overruns on construction projects.
Elemental Machines
Smart lab platform delivers powerful, data-driven insights that improve R&D, laboratory operations, and manufacturing outcomes.
Engine Biosciences
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Etcembly
Etcembly is building the worlds largest machine learning database and unmatched immunology.
Gauss Labs
Gauss Labs aims to revolutionize manufacturing by building industrial AI systems beyond human capabilities.
GrayMatter Robotics
GrayMatter Robotics creates solutions to assist humans in tedious and ergonomically challenging tasks.
Greenscreens AI
Greenscreens.ai is a freight market dynamic pricing infrastructure.
Hyperscience
Hyperscience is a technology company that develops AI-based enterprise software designed to automate office work processes.
Iterative.ai
Iterative.ai is an MLOps platform that develops lifecycle management for datasets and machine learning models.
Kintsugi
Kintsugi detects signs of clinical depression and anxiety using machine learning and voice biomarkers.
LatchBio
LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Nomitri
Retail AI Startup from Berlin. We develop Embedded Visual deep-learning AI for Mobile & Edge Devices.
Phenomic AI
Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.
Resemble AI
Resemble AI creates Custom Voices using proprietary Deep Learning models that can produce realistic Speech Synthesis.
StackStr
Real time monitoring of machine learning systems.
Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
Toggle
SaaS company building state-of-the-art AI technology to help investors turn Big Data into investment insights.
Current Advisors List
Current Employees Featured
Founder
Investors List
Leaps by Bayer
Leaps by Bayer investment in Series B - Metagenomi
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Metagenomi
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - Metagenomi
Millennium Management
Millennium Management investment in Series B - Metagenomi
HOF Capital
HOF Capital investment in Series B - Metagenomi
Deep Track Capital
Deep Track Capital investment in Series B - Metagenomi
Surveyor Capital
Surveyor Capital investment in Series B - Metagenomi
Novo Holdings
Novo Holdings investment in Series B - Metagenomi
Farallon Capital Management
Farallon Capital Management investment in Series B - Metagenomi
Marshall Wace
Marshall Wace investment in Series B - Metagenomi
Key Employee Changes
Official Site Inspections
http://www.metagenomi.co Semrush global rank: 1.99 M Semrush visits lastest month: 10.76 K
Unable to get host informations!!!
More informations about "Metagenomi"
About Us | Metagenomi
Dec 5, 2022 Metagenomi has developed the largest, most diverse, wholly-owned toolbox of gene editing systems through lead technologies and therapeutics programs. Skip to content. …See details»
Metagenomi - Crunchbase Company Profile & Funding
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular …See details»
SEC Filing | Metagenomi, Inc
Metagenomi, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware. 81-3909017 (State or other jurisdiction of. incorporation or organization) (I.R.S. Employer Identification No.) …See details»
SEC Filing | Metagenomi, Inc
Incorporation or organization) (Primary Standard Industrial. Classification Code Number) (I.R.S. Employer. Identification No.) Metagenomi Technologies, LLC . 1545 Park Avenue . Emeryville, …See details»
Discovery Platform - Metagenomi
Metagenomi is transforming novel gene editing tools, mined from the world’s natural microbial environment, into life-saving genetic medicines. Skip to content. Science. Discovery; ... [email protected]. Headquarters 5959 Horton St, …See details»
Metagenomi - Overview, News & Similar companies | ZoomInfo.com
Metagenomi has announced that Pamela Wapnick has joined the organization as Chief Financial Officer. Previously Wapnick served as Chief Financial Officer for Diality. ... 871-4880 Website: …See details»
Metagenomi - VentureRadar
Metagenomi is discovering breakthrough gene editing systems for curing genetic disease. Metagenomi is committed to changing the landscape of cell and gene therapies. By using …See details»
Metagenomi - Work in biotech
Founded in 2018, Metagenomi is based in Emeryville, CA. Through metagenomics and artificial intelligence (AI), they are able to uncover novel genetic machinery through the study of natural …See details»
Metagenomi Company Profile - Office Locations, Competitors, …
Jul 19, 2024 Metagenomi has 1 employees at their 1 location. See insights on Metagenomi including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Company: Metagenomi - CRISPR Medicine
Metagenomi is a start-up gene-editing company that applies its proprietary metagenomics-powered discovery platform to discover and develop next-generation gene-editing systems. …See details»
Metagenomi - Contacts, Employees, Board Members, Advisors
Organization. Metagenomi . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. Metagenomi has 6 current employee profiles, including Co-Founder …See details»
43rd Annual J.P. Morgan Healthcare Conference | Metagenomi, Inc
3 days ago The Investor Relations website contains information about Metagenomi, Inc's business for stockholders, potential investors, and financial analysts.See details»
Metagenomi to regain full development rights to its wholly-owned …
May 1, 2024 Metagenomi, Inc. Enhances strategic flexibility and control of key gene editing technologies and programs. EMERYVILLE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- …See details»
Metagenomi Highlights Progress Across Therapeutic Portfolio and ...
2 days ago MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency …See details»
SEC Filing | Metagenomi, Inc
1 This percentage is based on 37,428,994 shares of common stock, $0.0001 par value per share (the “Common Stock”) of Metagenomi, Inc., a Delaware corporation (the “Issuer”), outstanding …See details»
Metagenomi Highlights Progress Across Therapeutic Portfolio
2 days ago Metagenomi believes its diverse and modular toolbox positions the company to access the entire genome and select the optimal tool to unlock the full potential of genome …See details»
Gene Editing Toolbox | Metagenomi
Directed DNA integration has largely been considered the ultimate goal of corrective genome editing. This technology has the potential to address a large collection of complex genetic …See details»
Metagenomi Presents Novel, Highly Specific and Efficient Adenine …
Metagenomi believes its diverse and modular toolbox positions the company to access the entire genome and select the optimal tool to unlock the full potential of genome editing for patients. …See details»
Metagenomi, Inc. Welcomes Eric Bjerkholt to Board of Directors
3 days ago Here are some of the largest recent moves: EVENTIDE ASSET MANAGEMENT, LLC removed 583,041 shares (-100.0%) from their portfolio in Q3 2024; ARTAL GROUP S.A. …See details»
News - Metagenomi Recognized as One of World’s Most
Mar 2, 2023 Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation gene editing systems, has been named as one of Fast Company’s 16 …See details»